Connecting Research and Experts with Journalists

• share
• favorite_border

Researchers at The University of Texas M. D. Anderson Cancer Center have shined a bold new light on the future treatment of childhood leukemia. Results of a study published in the Jan. 30 issue of the New England Journal of Medicine not only refute a 30-year-old dogma universally held by the medical community, but also open new doors to a better understanding of acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. Using two sensitive assays, M. D. Anderson researchers found that up to thousands of leukemia cells may remain in a patient long after successful treatment.

• share
• favorite_border

EMBARGOED FOR RELEASE UNTIL 5 p.m., EST, THURSDAY, MARCH 27 HOUSTON -- Researchers at The University of Texas M. D. Anderson Cancer Center, in collaboration with Myriad Genetics, Inc. of Salt Lake City, have discovered a gene involved in the progression of a fatal form of brain cancer and a number of other cancers.

• share
• favorite_border

Postmenopausal women with advanced breast cancer treated with a new aromatase inhibitor live longer than patients treated with a commonly-used progestin, according to a report given today at the American Society of Clinical Oncology (ASCO).

• share
• favorite_border

Researchers at The University of Texas M. D. Anderson Cancer Center have found another anti-tumor drug that may prove useful in fighting lung cancer associated with smoking. The clinical trial at the Houston cancer center indicates the drug, topotecan, shows promise as a new treatment option for patients suffering from advanced non-small cell lung cancer.

• share
• favorite_border

An international study has found a new agent that may prove useful for treating patients with an aggressive brain tumor known as anaplastic astrocytoma.

• share
• favorite_border

Cancer patients wanting cutting-edge therapy or whose disease no longer responds to traditional treatment may find new hope on the "information super highway." The University of Texas M. D. Anderson Cancer Center has posted its clinical trials available for cancer patients on a World Wide Web site.

• share
• favorite_border

Findings of the Phase I medical study may have a huge impact on future treatments for the disease, especially for men with localized advanced prostate cancer, say Researchers at the University of Texas M. D. Anderson Cancer Centerr.

• share
• favorite_border

Smokers successfully treated for head and neck squamous cell cancer have greater chances of getting another cancer or having the cancer recur if they do not quit smoking, according to study at the University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

1- effectiveness of first oral chemotherapy for colon cancer; 2- new agent's promise against most serious brain tumors; 3- Taxotere increases survival rate for patients with non-small cell lung cancer.

• share
• favorite_border

The University of Texas M. D. Anderson Cancer Center is recruiting women for one of the largest breast cancer prevention studies conducted to date.